Surgical management of pancreatic neuroendocrine neoplasms
Pancreatic neuroendocrine neoplasms are relatively rare entities, representing approximately 1% to 2% of all pancreatic tumors. Owing to their rarity as well as their relatively indolent natural history, treatment approaches are not yet standardized. A formal pancreatic resection is usually mandator...
Main Authors: | Stefano Partelli, Angela Maurizi, Domenico Tamburrino, Stefano Crippa, Silvia Pandolfi, Massimo Falconi |
---|---|
Format: | Article |
Language: | English |
Published: |
King Faisal Specialist Hospital and Research Centre
2014-01-01
|
Series: | Annals of Saudi Medicine |
Online Access: | https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2014.1 |
Similar Items
-
Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms
by: Valentina Andreasi, et al.
Published: (2019-10-01) -
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.
by: Francesco Panzuto, et al.
Published: (2017-01-01) -
Imaging of Pancreatic Neuroendocrine Neoplasms
by: Giuditta Chiti, et al.
Published: (2021-08-01) -
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
by: Nicolò Pecorelli, et al.
Published: (2019-11-01) -
Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms
by: Giuseppinella Melita, et al.
Published: (2021-06-01)